PL409016A1 - N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection by influenza type A (IAV) virus and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine - Google Patents

N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection by influenza type A (IAV) virus and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine

Info

Publication number
PL409016A1
PL409016A1 PL409016A PL40901614A PL409016A1 PL 409016 A1 PL409016 A1 PL 409016A1 PL 409016 A PL409016 A PL 409016A PL 40901614 A PL40901614 A PL 40901614A PL 409016 A1 PL409016 A1 PL 409016A1
Authority
PL
Poland
Prior art keywords
polyallylamine
sulfonic
derivative
medicine
prevention
Prior art date
Application number
PL409016A
Other languages
Polish (pl)
Other versions
PL228503B1 (en
Inventor
Maria Nowakowska
Krzysztof Szczubiałka
Krzysztof Pyrć
Justyna Ciejka
Magdalena Wytrwał
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL409016A priority Critical patent/PL228503B1/en
Priority to PCT/IB2015/055727 priority patent/WO2016016820A2/en
Priority to US15/329,324 priority patent/US20170216347A1/en
Priority to EP15763979.0A priority patent/EP3174908B1/en
Priority to CA2955406A priority patent/CA2955406A1/en
Publication of PL409016A1 publication Critical patent/PL409016A1/en
Priority to US15/792,962 priority patent/US9925215B1/en
Publication of PL228503B1 publication Critical patent/PL228503B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem wynalazku jest N-sulfonowa pochodna polialliloaminy (NSPAH) o wzorze 1, w którym R oznacza -SO3 albo -H, a n oznacza liczbę całkowitą od 150 do 15000, zastosowanie N-sulfonowej pochodnej polialliloaminy jako leku, zwłaszcza do profilaktyki i leczenia infekcji wywołanych przez wirusy grypy typu A oraz kompozycja farmaceutyczna, zawierająca N-sulfonową pochodną polialliloaminy i jej zastosowanie.The subject of the invention is an N-sulfon derivative of polyallylamine (NSPAH) of the formula 1 in which R is -SO3 or -H, and n is an integer from 150 to 15,000, the use of the N-sulfon derivative of polyallylamine as a medicine, especially for the prevention and treatment of infections caused by by influenza A viruses and a pharmaceutical composition containing the N-sulfone derivative of polyallylamine and its use.

PL409016A 2014-07-29 2014-07-29 N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection by influenza type A (IAV) virus and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine PL228503B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PL409016A PL228503B1 (en) 2014-07-29 2014-07-29 N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection by influenza type A (IAV) virus and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine
PCT/IB2015/055727 WO2016016820A2 (en) 2014-07-29 2015-07-29 Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hmpv), human rhinoviruses (hrv), and infection by influenza virus type a (iav) and pharmaceutical composition comprising the anionically modified polyallylamine derivative
US15/329,324 US20170216347A1 (en) 2014-07-29 2015-07-29 Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hmpv), human rhinoviruses (hrv), and infection by influenza virus type a (iav) and pharmaceutical composition comprising the anionically modified polyallylamine derivative
EP15763979.0A EP3174908B1 (en) 2014-07-29 2015-07-29 Anionically modified n-sulfonic polyallylamine derivative, pharmaceutical composition comprising the n-sulfonic polyallylamine derivative as the active substance and use of the n-sulfonic polyallylamine derivative for the production of a medicine
CA2955406A CA2955406A1 (en) 2014-07-29 2015-07-29 Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hmpv), human rhinoviruses (hrv), and infection by influenza virus type a (iav) and pharmaceutical composition comprising the...
US15/792,962 US9925215B1 (en) 2014-07-29 2017-10-25 Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hMPV), human rhinoviruses (HRV), and infection by influenza virus type A (IAV) and pharmaceutical composition comprising the anionically modified polyallylamine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL409016A PL228503B1 (en) 2014-07-29 2014-07-29 N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection by influenza type A (IAV) virus and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine

Publications (2)

Publication Number Publication Date
PL409016A1 true PL409016A1 (en) 2016-02-01
PL228503B1 PL228503B1 (en) 2018-04-30

Family

ID=55178446

Family Applications (1)

Application Number Title Priority Date Filing Date
PL409016A PL228503B1 (en) 2014-07-29 2014-07-29 N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection by influenza type A (IAV) virus and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine

Country Status (1)

Country Link
PL (1) PL228503B1 (en)

Also Published As

Publication number Publication date
PL228503B1 (en) 2018-04-30

Similar Documents

Publication Publication Date Title
PH12017500207A1 (en) Indoles for use in influenza virus infection
EA201691261A1 (en) NEW DIHYDROCHINOLYSINES FOR THE TREATMENT AND PREVENTION OF INFECTION CAUSED BY THE HEPATITIS B VIRUS
EA201691726A1 (en) NEW 6-CONDENSED HETEROARYDYDYDROPYRIMIDIDES FOR THE TREATMENT AND PREVENTION OF HEPATITIS B VIRUS INFECTION
EA201690372A1 (en) AZAPIRIDON COMPOUNDS AND THEIR APPLICATION
CL2017001798A1 (en) Pyrazine compounds for the treatment of infectious diseases.
EA201491548A1 (en) 2'-SUBSTITUTED CARBANECULOSE ANALOGUES FOR ANTI-VIRUS TREATMENT
CY1122792T1 (en) MONO-OR DISUBTITUTED INDOLE DERIVATIVES AS DANGE VIRUS REPLICATION INHIBITORS
GEAP202115353A (en) Novel, highly active pyrazolo-piperidine substituted indole-2-carboxamides active against the hepatitis b virus (hbv)
EA201790571A1 (en) PYRROPHYRIMIDINES FOR APPLICATION IN INFECTION CAUSED BY THE FLU VIRUS
EA201790758A1 (en) Derivatives of mono-or dislocated indo as an inhibitor of dengue virus replication
MX383124B (en) FUSED TRICYCLIC PYRIDAZINONE COMPOUNDS USEFUL FOR TREATING ORTHOMYXOVIRUS INFECTIONS.
EA201500383A1 (en) DERIVATIVES 1,2,4-TRIAZINE FOR THE TREATMENT OF VIRAL INFECTIONS
EA201790700A1 (en) MONO OR DESIGNED INDOLS AS AN INHIBITORS REPLICATION OF DENG VIRUSES
EA201890722A1 (en) Derivatives of mono-or dislocated indo as an inhibitor of dengue virus replication
MX380393B (en) ATTENUATED INFLUENZA VECTORS FOR THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES AND FOR THE TREATMENT OF ONCOLOGICAL DISEASES.
EA201690371A1 (en) PYRIDAZINOUS COMPOUNDS AND THEIR APPLICATION
MX381314B (en) Aryl substituted pyrimidines for use in influenza virus infection
CY1118399T1 (en) Benzofuran compounds for viral infections c treatment
MX383931B (en) AZA-PYRIDONE COMPOUNDS AND THEIR USES.
BR112017000246A2 (en) compound, pharmaceutically acceptable salt of a compound, pharmaceutical composition, and use of a compound or salt
BR112016024235A2 (en) pharmaceutical compositions comprising antibacterial agents
EA201790632A1 (en) 4'-VINYL-SUBSTITUTED DERIVATIVES OF NUCLEOSIDE AS A RNA REPLICATION INHIBITOR INHIBITOR WITH RESPIRATORY SYNCYTAL VIRUS
EA201690594A1 (en) COMPOSITION FOR THE TREATMENT OF HIV INFECTION ON THE BASIS OF ATAZANAVIR AND COBICISTAT
EA201691792A1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON VILDAGLIPTINA
EA201790771A1 (en) PHARMACEUTICAL COMPOSITIONS OF LONG-TERM ACTION FOR THE TREATMENT OF HEPATITIS C